| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder |
| 06/20/2002 | US20020077304 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076446 Novel medicinal herbal composition for treating liver diseases and HIV |
| 06/20/2002 | US20020076421 Oral liquid mucoadhesive compositions |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/20/2002 | DE10063173A1 Harnstoff- und Urethanderivate Urea and urethane |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | DE10060292A1 Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament Use of substituted benzimidazoles for the manufacture of a medicament for the treatment of diseases which can be influenced by inhibiting the Na + / H + exchanger and containing medicament |
| 06/20/2002 | CA2445091A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 06/20/2002 | CA2431406A1 Quinazolinone derivatives |
| 06/20/2002 | CA2431173A1 Chronic treatment regimen using glucagon-like insulinotropic peptides |
| 06/20/2002 | CA2431107A1 Antitumoral carbazoles |
| 06/20/2002 | CA2431044A1 Oral compositions and use thereof |
| 06/20/2002 | CA2430992A1 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/20/2002 | CA2365494A1 Lawsonia intracellularis vaccine |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214323A1 Indoloazepines as vasopressin receptor antagonists |
| 06/19/2002 | EP1214313A2 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214093A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214061A2 Use of docetaxel for treating hepatocellular carcinoma |
| 06/19/2002 | EP1213975A2 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds, and therapeutic, cosmetical or food use of said compounds |
| 06/19/2002 | EP0975623B1 Indazole amide compounds as serotoninergic agents |
| 06/19/2002 | EP0754061B1 New oral pharmaceutical dosage form |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0574487B1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
| 06/19/2002 | CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 06/19/2002 | CN1354737A Novel derivatives of 3-3-diphenylpropylamines |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354658A New use of compounds as antibacterial agents |
| 06/19/2002 | CN1354656A Compositions and methods for mucosal delivery |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354015A Health-care product containing growth factor and its preparation method |
| 06/19/2002 | CN1354014A Gongbu ointment |
| 06/19/2002 | CN1354012A Compound Chinese medicine tea bag for curing fatty liver and hyperlipemia and its production method |
| 06/19/2002 | CN1354008A Helth-care product with functions of prolonging life and nourishing face |
| 06/19/2002 | CN1354002A Medicine for curing gastrointestinal diseases and its production method |
| 06/19/2002 | CN1353996A Chinese medicine for double recuperation of gastrointestinal function |
| 06/19/2002 | CN1353986A Antibiotic agent of antihelicobacter pylori containing chelate compound |
| 06/19/2002 | CN1086301C Gargle for curing toothache |
| 06/19/2002 | CN1086300C Medicine for curing hepatopathy |
| 06/19/2002 | CN1086294C Health care liquid and its preparation method |
| 06/18/2002 | US6407250 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| 06/18/2002 | US6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them |
| 06/18/2002 | US6407106 For therapy of inflammatory disturbances of the gastrointestinal tract |
| 06/18/2002 | US6407104 Pyrrolo[1,2-a]pyrazine spla2 inhibitor |
| 06/18/2002 | US6407095 Treating nicotinic receptor, gastrointestinal, nervous system, psychological, and brain disorders |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407073 Use of coumarin derivatives for the treatment of digestive tract disorders |
| 06/18/2002 | US6407067 Salts of thrombin inhibitors |
| 06/18/2002 | US6407058 Phosphorylation of serine or threonine |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
| 06/13/2002 | WO2002046394A1 Novel g protein-coupled receptor protein and dna thereof |
| 06/13/2002 | WO2002046385A2 Enzymes |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046226A2 Trefoil factor 2 (tff2) peptides with moiety attached to asn15 |
| 06/13/2002 | WO2002046225A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 06/13/2002 | WO2002046193A2 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046192A2 Thioether substituted imidazoquinolines |
| 06/13/2002 | WO2002046191A2 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | WO2002046190A2 Sulfonamido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046189A2 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046188A2 Amido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046169A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands |
| 06/13/2002 | WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 06/13/2002 | WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002046147A2 Perturbed membrane-binding compounds |
| 06/13/2002 | WO2002046138A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines |